• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Severity of COVID-19 in end-stage kidney disease patients on chronic dialysis.接受长期透析的终末期肾病患者感染新型冠状病毒肺炎的严重程度
Ther Apher Dial. 2021 Oct;25(5):706-709. doi: 10.1111/1744-9987.13597. Epub 2020 Oct 27.
2
[Reception of patients with chronic renal failure, COVID-19].[慢性肾衰竭患者合并新型冠状病毒肺炎的收治]
Rev Infirm. 2021 May;70(271):41-42. doi: 10.1016/j.revinf.2021.03.017. Epub 2021 Apr 6.
3
Confirmed Drop in Treatment of Patients with Incident End-Stage Kidney Disease During the Novel Coronavirus Disease 2019 Pandemic.2019年新型冠状病毒病大流行期间确诊的终末期肾病患者治疗量下降
J Am Soc Nephrol. 2022 Feb;33(2):455. doi: 10.1681/ASN.2021101296.
4
Long-Term Hemodialysis during the COVID-19 Pandemic.新冠疫情期间的长期血液透析
Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1073-1074. doi: 10.2215/CJN.09100620. Epub 2020 Jul 2.
5
The COVID-19 pandemic: consequences for nephrology.COVID-19 大流行：对肾脏病学的影响。
Nat Rev Nephrol. 2021 Feb;17(2):81-82. doi: 10.1038/s41581-020-00381-4.
6
Factors related to mortality in patients with stage 5 chronic kidney disease on dialysis with COVID-19: An exploratory case series analysis.接受透析治疗的5期慢性肾病合并COVID-19患者的死亡相关因素：一项探索性病例系列分析。
Medwave. 2022 Dec 29;22(11):e2562. doi: 10.5867/medwave.2022.11.2562.
7
Effects of SARS-CoV-2 vaccination on the severity of COVID-19 infection in patients on chronic dialysis.SARS-CoV-2 疫苗接种对慢性透析患者 COVID-19 感染严重程度的影响。
J Nephrol. 2023 Jun;36(5):1321-1328. doi: 10.1007/s40620-023-01617-9. Epub 2023 Apr 5.
8
Diverse antibody responses to SARS-CoV-2 infection in patients with end-stage kidney disease undergoing hemodialysis.接受血液透析的终末期肾病患者对SARS-CoV-2感染的多种抗体反应。
Ther Apher Dial. 2022 Apr;26(2):473-474. doi: 10.1111/1744-9987.13746. Epub 2021 Oct 21.
9
Novel coronavirus disease in patients with end-stage kidney disease.新型冠状病毒病患者的终末期肾病。
Ther Apher Dial. 2021 Oct;25(5):544-550. doi: 10.1111/1744-9987.13599. Epub 2020 Oct 27.
10
Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective.为何以及如何应在 2019 冠状病毒病大流行期间和之后提倡终末期肾病患者进行家庭透析？法国的观点。
J Nephrol. 2021 Aug;34(4):985-989. doi: 10.1007/s40620-021-01061-7. Epub 2021 Jun 1.

引用本文的文献

1
One-year Survival of End-Stage Kidney Disease Patients Undergoing Hemodialysis in Indonesia.印度尼西亚接受血液透析的终末期肾病患者的一年生存率
Int J Nephrol Renovasc Dis. 2025 Mar 12;18:87-101. doi: 10.2147/IJNRD.S508012. eCollection 2025.
2
Cellular and humoral response to SARS-CoV-2 vaccine BNT162b2 in adults with Chronic Kidney Disease G4/5.慢性肾脏病G4/5期成人对SARS-CoV-2疫苗BNT162b2的细胞和体液反应
New Microbes New Infect. 2024 Aug 18;62:101458. doi: 10.1016/j.nmni.2024.101458. eCollection 2024 Dec.
3
Antibody Response to SARS-CoV-2 Vaccination in Patients with End-Stage Kidney Disease on Hemodialysis.血液透析终末期肾病患者对SARS-CoV-2疫苗接种的抗体反应
Vaccines (Basel). 2023 Dec 1;11(12):1802. doi: 10.3390/vaccines11121802.
4
Characteristics of the 6th Japanese wave of COVID-19 in hemodialysis patients.日本第6波新冠疫情在血液透析患者中的特征
Ren Replace Ther. 2022;8(1):61. doi: 10.1186/s41100-022-00451-2. Epub 2022 Dec 2.
5
COVID-19 among Chronic Dialysis Patients after First Year of Pandemic, Argentina.大流行后第一年阿根廷慢性透析患者中的 COVID-19。
Emerg Infect Dis. 2022 Nov;28(11):2294-2297. doi: 10.3201/eid2811.212597. Epub 2022 Oct 3.
6
Risk factors associated with COVID-19 severity among patients on maintenance haemodialysis: a retrospective multicentre cross-sectional study in the UK.维持性血液透析患者 COVID-19 严重程度相关的危险因素：英国一项回顾性多中心横断面研究。
BMJ Open. 2022 May 30;12(5):e054869. doi: 10.1136/bmjopen-2021-054869.
7
Clinical presentation and outcomes of chronic dialysis patients with COVID-19: A single center experience from Greece.新型冠状病毒肺炎慢性透析患者的临床表现及预后：来自希腊的单中心经验
World J Nephrol. 2022 Mar 25;11(2):58-72. doi: 10.5527/wjn.v11.i2.58.
8
Elevated De Ritis Ratio Is Associated With Poor Prognosis in COVID-19: A Systematic Review and Meta-Analysis.德瑞蒂斯比值升高与COVID-19的不良预后相关：一项系统评价和荟萃分析
Front Med (Lausanne). 2021 Dec 22;8:676581. doi: 10.3389/fmed.2021.676581. eCollection 2021.
9
The effects of aspirin on the outcome of COVID-19: A systematic review and meta-analysis.阿司匹林对新型冠状病毒肺炎结局的影响：一项系统评价与荟萃分析
Clin Epidemiol Glob Health. 2021 Oct-Dec;12:100883. doi: 10.1016/j.cegh.2021.100883. Epub 2021 Oct 30.
10
The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: Systematic review and meta-analysis.在新冠肺炎住院患者中使用 Janus 激酶抑制剂：系统评价与荟萃分析。
Clin Epidemiol Glob Health. 2021 Jul-Sep;11:100755. doi: 10.1016/j.cegh.2021.100755. Epub 2021 May 2.

本文引用的文献

1
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19.伴有 COVID-19 的终末期肾病患者的住院结果。
Kidney Int. 2020 Dec;98(6):1530-1539. doi: 10.1016/j.kint.2020.07.030. Epub 2020 Aug 15.
2
COVID-19 Outbreak in a Hemodialysis Center: A Retrospective Monocentric Case Series.一家血液透析中心的 COVID-19 疫情：一项回顾性单中心病例系列研究。
Can J Kidney Health Dis. 2020 Jul 24;7:2054358120944298. doi: 10.1177/2054358120944298. eCollection 2020.
3
Epidemiological, Clinical, and Immunological Features of a Cluster of COVID-19-Contracted Hemodialysis Patients.一群感染新冠病毒的血液透析患者的流行病学、临床和免疫学特征
Kidney Int Rep. 2020 Jun 9;5(8):1333-1341. doi: 10.1016/j.ekir.2020.06.003. eCollection 2020 Aug.
4
Clinical characteristics of 31 hemodialysis patients with 2019 novel coronavirus: a retrospective study.31例新型冠状病毒2019感染血液透析患者的临床特征：一项回顾性研究。
Ren Fail. 2020 Nov;42(1):726-732. doi: 10.1080/0886022X.2020.1796705.
5
COVID-19 Outbreak in an Urban Hemodialysis Unit.城市血液透析单元中的 COVID-19 疫情爆发。
Am J Kidney Dis. 2020 Nov;76(5):690-695.e1. doi: 10.1053/j.ajkd.2020.07.001. Epub 2020 Jul 15.
6
Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea.中心血液透析患者的新型冠状病毒肺炎结局：来自韩国疫情中心的经验
J Clin Med. 2020 Jun 2;9(6):1688. doi: 10.3390/jcm9061688.
7
Presentation and Outcomes of Patients with ESKD and COVID-19.终末期肾病患者合并 COVID-19 的表现和结局。
J Am Soc Nephrol. 2020 Jul;31(7):1409-1415. doi: 10.1681/ASN.2020040470. Epub 2020 May 28.
8
COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain.COVID-19：西班牙 36 名血液透析患者的临床病程和转归。
Kidney Int. 2020 Jul;98(1):27-34. doi: 10.1016/j.kint.2020.04.031. Epub 2020 May 11.
9
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection.布雷西亚肾脏 COVID 工作组关于 SARS-CoV-2 感染血液透析患者的临床特征和短期结局的报告。
Kidney Int. 2020 Jul;98(1):20-26. doi: 10.1016/j.kint.2020.04.030. Epub 2020 May 8.

Severity of COVID-19 in end-stage kidney disease patients on chronic dialysis.

作者信息

Andhika Rizky, Huang Ian, Wijaya Indra

机构信息

Division of Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia.

Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia.

出版信息

Ther Apher Dial. 2021 Oct;25(5):706-709. doi: 10.1111/1744-9987.13597. Epub 2020 Oct 27.

DOI:10.1111/1744-9987.13597
PMID:33040468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7675666/
Abstract
摘要